Navigation Links
Feinstein Institute, Hofstra North Shore-LIJ School of Medicine at 36th Annual Conference on Shock
Date:6/5/2013

Twelve investigators from The Feinstein Institute for Medical Research and four researchers from the Hofstra North Shore-LIJ School of Medicine attended and participated in the 36th Annual Conference on Shock on June 1-4 in San Diego, CA.; Kevin J. Tracey, MD, president of the Feinstein Institute, provided the keynote address, and Ping Wang, MD, served as the meeting's program chair.

"I am thrilled that so many from the Feinstein Institute and the Hofstra North Shore-LIJ School of Medicine had a strong presence at this year's Shock Society," said Kevin J. Tracey, MD. "This demonstrates the strength in our research and dedication in the area of inflammation."

The Shock Society selects five out of approximately 60 applicants to receive the new investigator award, in which the finalists are recognized with a plaque, a cash award (first place $600, four other finalists $350) and a travel grant of $1,000. Sergio Valdes-Ferrer, MD, an investigator at the Feinstein Institute, was a finalist, and Matthew Giangola, MD, a post-doctoral research fellow at the Hofstra North Shore-LIJ School of Medicine, won the second prize.

"Resident researchers from the Department of Surgery at the North Shore-LIJ Health System were finalists in the Shock Society's New Investigator Competition for the last three consecutive years. They took first prize in 2011 and 2012, and this year, Dr. Giangola won second prize," noted Jeffrey Michael Nicastro, MD, vice chair of surgery for the North Shore-LIJ Health System. "This acknowledgment of the Department of Surgery's prowess in scientific contributions is greatly appreciated and well deserved."

In addition, 40 travel grants of up to $1,000 for travel and lodging expenses are provided by the Shock Society to investigators based on scientific merit and financial need. Two Feinstein Institute investigators Cletus Cheyuo, MD, PhD, and Sergio Valdes-Ferrer, MD and two Hofstra North Shore-LIJ School of Medicine investigators Matthew Giangola, MD, and Michael Kuncewitch, MD were awarded travel grants.

Details on what the twelve Feinstein Institute investigators presented at the annual meeting are below (in order of when they presented at the meeting):

  • Ping Wang, MD, program chair of the meeting, provided the welcome and introductions
  • Sangeeta Chavan, PhD, presented abstract 1, "Transcutaneous Auricular Vagus Nerve Stimulation Attenuates Pro-Inflammatory Cytokine Response in Healthy Volunteers"
  • Cletus Cheyuo, MD, PhD, presented abstract 7, "MFG-E8 Regulates Neural Stem Cell Proliferation and Migration via Integrin AVB3/PPARGamma/Cyclin D2/Netrin-1 Pathway"
  • Kevin J. Tracey, MD, president of the Feinstein Institute, presented the keynote address entitled "Reflex Integration of Inflammasome Responses"
  • Sergio Valdes-Ferrer, MD, presented abstract 9, "HMGB1 Mediates Persistent Splenomegaly, Leukocytosis, and Splenocyte Priming in Sepsis Survivors"
  • Haichao Wang, PhD, presented a mini-symposium, entitled "Sepsis: Mechanism and Therapeutics"
  • Ben Lu, MD, presented abstract 19, "Cholinergic Neuronal Signals Attenuate Inflammasome Activation Through Inhibiting Mitochondrial Stress"
  • Barbara Sherry, PhD, presented a symposium, entitled "Parallel Symposium II: Cytokine and Chemokine Regulation" and "Dysregulated Cell Trafficking in Sepsis: Mechanisms and Clinical Consequences"
  • Wei Li, MD, PhD, presented abstract 35, "Carbenoxlone Blocks LPS-Induced HMGB1 Release by Impairing PKR Activation"
  • Christine Metz, PhD, presented a mini-symposium, entitled "Inflammation Signaling"
  • Huan Yang, PhD, presented abstract 37, "HMGB1 Binds to MD-2 in the TLR4/MD2 Complex to Elicit Inflammatory Responses"
  • Edmund J. Miller, PhD, presented a mini-symposium, entitled "Ischemia and Reperfusion Injury"

"Not only were there 12 investigators from the Feinstein Institute who made presentations at this meeting, there were also approximately 15 more investigators who demonstrated their research posters," noted Ping Wang, MD, an investigator at the Feinstein Institute and vice chair for research in the North Shore-LIJ Department of Surgery. "I am proud of this sizeable attendance, but moreover, I am proud of these investigator's achievements and the quality of their research presentations these efforts placed the Feinstein Institute at the top in shock research."

Details on what the four Hofstra North Shore-LIJ School of Medicine investigators presented at the annual meeting are below (in order of when they presented at the meeting):

  • Weng-Lang Yang, PhD, presented "Cold-Inducible RNA-Binding Protein (CIRP): A New Player in Inflammation"
  • Michael Kuncewitch, MD, presented abstract 6, "Inhibition of Fatty Acid Synthase with C75 Reduces Organ Injury After Hemorrhagic Shock"
  • Matthew Giangola, MD, presented abstract 11, "Growth Arrest-Specific Protein 6 (GAS6) Attenuates Neutrophil Migration and Acute Lung Injury in Sepsis"
  • Shingo Matsuo, MD, presented abstract 13, "PYR-41, a Ubiquitin-Activating Enzyme E1 Inhibitor, Attenuates Organ Injury in Sepsis"


'/>"/>

Contact: Emily Ng
eng3@nshs.edu
516-562-2670
North Shore-Long Island Jewish (LIJ) Health System
Source:Eurekalert

Related medicine news :

1. North Shore-LIJ's Feinstein Institute Hosts Academic Commencement and Convocation
2. North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week
3. Feinstein Institute Researcher provides insight into osteoarthritis
4. Feinstein Institute Scientist Wins Crafoord Award from Royal Swedish Academy of Sciences for Arthritis Research
5. A Feinstein Institute for Medical Research Study Shows Early Cognitive Problems among Those Who Eventually Get Alzheimer's
6. Feinstein Institute researchers discover plant derivative
7. Feinstein announces submission of new drug application for diagnosing parkinsonian syndromes
8. Feinstein Institute researchers discover that bean used in Chinese food could protect against sepsis
9. Feinstein Institute to Receive Grant from Centers for Medicare & Medicaid Services to Improve Schizophrenia Treatment
10. Feinstein Institute to receive grant to improve schizophrenia treatment
11. Roswell Park Cancer Institute, Jasco Pharmaceuticals Join Forces to Advance Development of Anticancer Agent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... Pitavastatin, a relatively new statin, ... not known to have significant interactions with antiretroviral therapy (ART). Among people ... and dampen inflammation in the bloodstream. , While lowering cholesterol and dampening inflammation ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... that over the last decade, student well-being has seriously declined. "When disenfranchised youth ... formal education, join the Islamic State to turn the historic multi-ethnic and multi-religious ...
(Date:4/24/2017)... ... 24, 2017 , ... Life of Purpose Treatment is proud to present “An ... held at 7:30 pm on May 10th at the University Auditorium. , This benefit ... will support the UF Collegiate Recovery Community (UFCRC). The concert will kick off the ...
(Date:4/23/2017)... ... April 23, 2017 , ... Altura ... the achievement of Cisco Select certification and SMB specialization. Altura is now ... , In earning the Select Certification, Altura fulfilled the training and exam ...
(Date:4/22/2017)... San Juan Capistrano (PRWEB) , ... April 22, 2017 , ... The San Juan ... have recently released a parenting report outlining the need for summer camps to provide physical ... , The Importance of Physical Activity In Summer Camps , With an increase in specialty ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017 Eyevensys, a private biotechnology ... gene expression technology that enables the safe, local, sustained ... a wide range of ophthalmic diseases, announces it has ... Regulatory Agency (MHRA) to advance its technology into clinical ... The ...
(Date:4/19/2017)... 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the ... Co. Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Chief Executive Officer of the Company is scheduled to present on ... Bear and the Chairman of the Board, Tony Holler ... ...
(Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
Breaking Medicine Technology: